Sharda Cropchem Ltd

The investor presentation for Sharda Cropchem Limited (SHARDACROP) for the quarter and half year ended 30th September 2026 outlines the company's financial performance and strategic direction. For Q2 FY27, revenue reached Rs. 1,052 Crs, reflecting a 13% YoY growth, with the agrochemical segment contributing Rs. 840 Crs (+5% YoY) and the non-agrochemical segment Rs. 212 Crs (+68% YoY). Gross profit was Rs. 378 Crs (+18% YoY), and EBITDA stood at Rs. 164 Crs (+18% YoY), with an EBITDA margin of 15.6% (+70 bps YoY). For H1 FY27, total revenue was Rs. 2,125 Crs (+11% YoY), with EBITDA at Rs. 343 Crs (+22% YoY) and an EBITDA margin of 16.1% (+140 bps YoY). Regionally, LATAM showed significant growth (+81% YoY in Q2 and +69% YoY in H1), while Europe declined (-7% YoY in Q2 and -9% YoY in H1). The balance sheet reported total equity of Rs. 3,250 Crs and cash, bank, and liquid investments of Rs. 846 Crs as of 30th September 2026. The company emphasized its IP-led growth model, global distribution network, and strategic focus on regulatory assets and operational efficiency. Management highlighted plans to strengthen the sales force, expand distribution, and continue investing in registrations. The presentation also included historical financial data showing consistent revenue growth and improving margins over the past few fiscal years.

The document emphasizes growth in revenue, EBITDA, and margins, along with strategic initiatives and strong financial metrics.